When reproductive care ends: the cardiometabolic continuity gap in PMOS in low- and middle-income countries—a mini-review

OBJECTIVE: To examine the potential cardiometabolic continuity gap after reproductive care among women with polyendocrine metabolic ovarian syndrome (PMOS), particularly in low- and middle-income countries.Methods This mini-review synthesizes evidence on persistent glycaemic, adiposity-related, blood-pressure, lipid, and cardiovascular risk and examines where responsibility for follow-up may become fragmented in low- and middle-income countries. RESULTS: PMOS, formerly polycystic ovary syndrome, is a lifelong multisystem condition whose cardiometabolic implications persist beyond fertility treatment, pregnancy, and childbirth. Yet care often remains organized around reproductive goals, creating a potential continuity gap when women transition from fertility, maternity, or postpartum services to primary or noncommunicable disease care. This review proposes a minimum continuity pathway: Identify, Document, Transfer, Reassess, and Retain. CONCLUSIONS: The pathway defines essential functions rather than a fixed service model and requires local adaptation and prospective evaluation. Reproductive care may end, but cardiometabolic responsibility should not; every woman leaving reproductive care should have a documented risk profile, a clearly identified next service, and an accessible route to continuing follow-up.